Video Experimental Relacionado
Updated: Aug 19, 2026
03:53
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
La fibrosis quística. también conocida como fibrosis quística. Un desafío creciente para la medicina interna
JAMA
|November 14, 1977
Resumen
El número de adultos con fibrosis quística (FC) que reciben atención está aumentando en 200 pacientes al año. Las proyecciones indican casi 4.000 adultos en el cuidado de la FQ para 1985, con modelos que sugieren una futura población de equilibrio entre 24.000 y 64.000.
Área de la Ciencia:
- Pulmonología Pulmonología.
- Genética La genética.
- Epidemiología La epidemiología.
Sus antecedentes:
- El número de adultos con fibrosis quística (FQ) que reciben atención de los Centros de FQ de los Estados Unidos está aumentando.
- Esta tendencia requiere proyecciones de población actualizadas para una planificación efectiva de la atención médica.
Objetivo del estudio:
- Para modelar y predecir la futura población adulta con fibrosis quística (FC) bajo varios escenarios.
- Para estimar el tamaño potencial de la población adulta de FQ en equilibrio.
Principales métodos:
- Extrapolación del aumento anual actual en pacientes adultos con FQ.
- Desarrollo de cuatro modelos adicionales basados en escenarios de estado estacionario.
- La inclusión de variaciones como una reducción del 50% de la mortalidad y el cribado universal de recién nacidos.
Principales resultados:
- Un modelo que proyecta 4.000 adultos en el cuidado de la FQ para fines de 1985 basado en las tendencias actuales.
- Los modelos de población de equilibrio indican un rango de 24.000 a 64.000 pacientes en total.
- Estos modelos de equilibrio sugieren entre 7.000 y 18.000 adultos dentro de la población de pacientes.
Conclusiones:
- La población adulta con fibrosis quística (FQ) está creciendo, lo que requiere una asignación proactiva de recursos de atención médica.
- El tamaño de la población futura depende en gran medida de las tasas de mortalidad y las intervenciones de detección.
- La planificación a largo plazo para los centros de atención para adultos con FQ debe considerar una cohorte de pacientes significativamente más grande.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...